Trials / Recruiting
RecruitingNCT06267365
Predictive Biomarker for Endoscopic Therapy in Chronic Pancreatitis
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (estimated)
- Sponsor
- NYU Langone Health · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is an observational prospective study to develop predictive biomarkers for pain response in participants with chronic pancreatitis scheduled for endoscopic therapy. Participants will undergo baseline assessments including electroencephalography (EEG), quantitative sensory testing (QST), and psychosocial questionnaires. Response to endoscopic therapy will be assessed at approximately 3, 6, 12 and 18 months post-procedure using questionnaires.
Conditions
Timeline
- Start date
- 2023-11-27
- Primary completion
- 2027-03-01
- Completion
- 2028-06-01
- First posted
- 2024-02-20
- Last updated
- 2025-12-17
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06267365. Inclusion in this directory is not an endorsement.